Mackenzie Financial’s CONMED CNMD Stock Holding History

Mackenzie Financial’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$213K	Buy	+6,498	New	+$234K	﹤0.01%	1481
2023 Q3	–	Sell	-1,753	Closed	-$235K	–	1491
2023 Q2	$235K	Buy	+1,753	New	+$214K	﹤0.01%	1271
2022 Q2	–	Sell	-1,645	Closed	-$244K	–	1472
2022 Q1	$244K	Buy	1,645 +73	+5%	+$10.2K	﹤0.01%	1213
2021 Q4	$223K	Sell	1,572 -132	-8%	-$18.7K	﹤0.01%	1287
2021 Q3	$223K	Buy	+1,704	New	+$223K	﹤0.01%	1267
2016 Q4	–	Sell	-9,713	Closed	-$389K	–	655
2016 Q3	$389K	Hold	9,713	–	–	﹤0.01%	529
2016 Q2	$464K	Hold	9,713	–	–	﹤0.01%	769
2016 Q1	$407K	Hold	9,713	–	–	﹤0.01%	690
2015 Q4	$428K	Buy	+9,713	New	+$422K	﹤0.01%	698

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Mackenzie Financial's CNMD Position: Q2 2026 in Review

Mackenzie Financial opened a new position in CONMED (CNMD) in Q2 2026: 6,498 shares worth $213K. The stake represents ﹤0.01% of the portfolio and ranks #1481 among its holdings. This is a return to the name: Mackenzie Financial previously reported a position in CNMD as recently as Q2 2023.

Mackenzie Financial first reported a position in CNMD in Q4 2015 and has held it in 9 quarters since. The position peaked at $464K in Q2 2016. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Mackenzie Financial held 6,498 shares of CONMED worth $213K as of Q2 2026.
CONMED was a new Mackenzie Financial position in Q2 2026.
CONMED made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #1481 holding.
Mackenzie Financial first reported a position in CONMED in Q4 2015 and has held it in 9 quarters since.
Mackenzie Financial's CONMED position peaked at $464K in Q2 2016.
247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.